DK315187A - Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekser - Google Patents

Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekser

Info

Publication number
DK315187A
DK315187A DK315187A DK315187A DK315187A DK 315187 A DK315187 A DK 315187A DK 315187 A DK315187 A DK 315187A DK 315187 A DK315187 A DK 315187A DK 315187 A DK315187 A DK 315187A
Authority
DK
Denmark
Prior art keywords
unsolutable
immunic
complexs
antibodies
procedure
Prior art date
Application number
DK315187A
Other languages
English (en)
Other versions
DK315187D0 (da
Inventor
Jr Alton C Morgan
Clive S Woodhouse
Robert F Mcintyre
Original Assignee
Neorx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neorx Corp filed Critical Neorx Corp
Publication of DK315187D0 publication Critical patent/DK315187D0/da
Publication of DK315187A publication Critical patent/DK315187A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6056—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK315187A 1986-06-20 1987-06-19 Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekser DK315187A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87682886A 1986-06-20 1986-06-20
US07/024,632 US4879225A (en) 1986-06-20 1987-03-11 Enhanced production of antibodies utilizing insolubilized immune complexes

Publications (2)

Publication Number Publication Date
DK315187D0 DK315187D0 (da) 1987-06-19
DK315187A true DK315187A (da) 1987-12-21

Family

ID=26698676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK315187A DK315187A (da) 1986-06-20 1987-06-19 Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekser

Country Status (7)

Country Link
US (1) US4879225A (da)
EP (1) EP0251065A3 (da)
JP (1) JPS63258496A (da)
CN (1) CN87105716A (da)
AU (1) AU615628B2 (da)
DK (1) DK315187A (da)
NO (1) NO872581L (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3565289A (en) * 1988-05-05 1989-11-29 National Research Development Corporation Immunogenic complex and its use in vaccination
EP0529007A1 (en) 1990-04-18 1993-03-03 The Regents Of The University Of California A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION
US5723115A (en) * 1991-05-02 1998-03-03 W. Alton Jones Cell Science Center, Inc. Inhibition of adipose tissue development and obesity
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5283066A (en) * 1992-02-19 1994-02-01 Development Center For Biotechnology Method of stimulating an immune response by using a hapten
CA2098960C (en) * 1992-07-10 2004-11-02 Richard Barner Bio specifically recognizing surfaces on solid supports and method for their preparation
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
DE69435318D1 (de) 1993-01-28 2010-12-09 Boston Scient Ltd Therapeutische inhibitoren der zellen der glatten gefässmuskulatur
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US7611533B2 (en) 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
GB9606425D0 (en) * 1996-03-27 1996-06-05 Binding Site Ltd Improvements in and relating to the production of antibodies and test kits incorporating antibodies
US20080220012A1 (en) * 1996-05-15 2008-09-11 Ragupathy Madiyalakan Therapeutic Compositions that alter the immune response
US7318921B2 (en) * 1996-05-15 2008-01-15 Altarex Medical Corp. Therapeutic compositions that alter the immune response
US8038994B2 (en) * 1996-05-15 2011-10-18 Quest Pharmatech Inc. Combination therapy for treating disease
SI0910407T1 (en) * 1996-05-15 2003-10-31 Altarex Corp. Method and composition for reconforming multi-epitopic antigens to initiate an immune response
US20060159688A1 (en) * 1996-05-15 2006-07-20 Ragupathy Madiyalakan Method for diagnosing efficacy of xenotypic antibody therapy
US7361346B1 (en) * 1996-05-15 2008-04-22 Altarex Corp. Therapeutic compositions that produce an immune response
ATE278397T1 (de) 1997-03-31 2004-10-15 Boston Scient Ltd Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
CA2363067C (en) 1999-01-12 2012-03-20 David J. Grainger Compounds and methods to inhibit or augment an inflammatory response
US7009040B2 (en) * 2003-01-21 2006-03-07 Arius Research, Inc. Cancerous disease modifying antibodies
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
WO2003086041A2 (en) * 2002-04-11 2003-10-23 Altarex Medical Corporation Binding agents and their use in targeting tumor cells
US7393531B2 (en) * 2003-01-21 2008-07-01 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP
US7468254B2 (en) * 2003-01-21 2008-12-23 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP
JP3600231B1 (ja) * 2003-09-30 2004-12-15 森永製菓株式会社 イムノアッセイ
WO2019199918A1 (en) * 2018-04-11 2019-10-17 Cowan Fred M Compositions and methods for prevention and treatment of immune complex disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031812B1 (en) * 1979-03-27 1983-06-15 National Research Development Corporation Improvements in or relating to immunological preparations
IL63220A (en) * 1981-07-01 1985-09-29 Yeda Res & Dev Process for production of polyacrolein microspheres
US4471058A (en) * 1982-07-26 1984-09-11 Board Of Trustees Operating Michigan State University Method for the detection and/or determination of a polyvalent antigen using at least two different monoclonal antibodies
US4693966A (en) * 1983-03-11 1987-09-15 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies from lymphocytes of patients with malignant melanoma
FR2558165B1 (fr) * 1984-01-17 1986-07-04 Anvar Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages

Also Published As

Publication number Publication date
EP0251065A2 (en) 1988-01-07
CN87105716A (zh) 1988-06-08
NO872581D0 (no) 1987-06-19
US4879225A (en) 1989-11-07
AU615628B2 (en) 1991-10-10
AU7449687A (en) 1987-12-24
NO872581L (no) 1987-12-21
DK315187D0 (da) 1987-06-19
JPS63258496A (ja) 1988-10-25
EP0251065A3 (en) 1989-08-30

Similar Documents

Publication Publication Date Title
DK315187D0 (da) Fremgangsmaade til forbedret fremstilling af antistoffer under anvendelse af uoploeseliggjorte immunkomplekser
DK238988D0 (da) Fremgangsmaade til fremstilling af 4-acyloxy-3-hydroxyethyl-azetidinoner
DK65185D0 (da) Fremgangsmaade til fremstilling af antistof
DK129085A (da) Fremgangsmaade til fremstilling af proteiner
FI881866A0 (fi) Perunakuidun valmistusmenetelmä
DK104487D0 (da) Fremgangsmaade til fremstilling af kanelsyrer
DK78388A (da) Fremgangsmaade til fremstilling af 4-acetoxy-3-hydroxyethyl-azetidinon
DK28788A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK471588D0 (da) Fremgangsmaade til fremstilling af polymerer
DK184687A (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK231987A (da) Fremgangsmaade til fremstilling af 2,3-epoxyamider
DK203887A (da) Fremgangsmaade til fremstilling af roerformede fiberemner
DK117487D0 (da) Fremgangsmaade til fremstilling af inulase
DK533287D0 (da) Fremgangsmaade til fremstilling af azetidinoner
DK329685A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalaninalkylestere
DK361387A (da) Fremgangsmaade til fremstilling af piperidinopyrimidin
DK190187D0 (da) Fremgangsmaade til fremstilling af n-aminophthalimid
DK60287D0 (da) Fremgangsmaade til fremstilling af 4-acetyl-isoquinolinon-forbindelser
DK450087D0 (da) Fremgangsmaade til fremstilling af proteiner
DK280187D0 (da) Fremgangsmaade til fremstilling af metalloproteinkonjugater
DK142788D0 (da) Fremgangsmaade til fremstilling af chlorerede olefiner
DK350288A (da) Fremgangsmaade til fremstilling af n-epoxypropyllactamer
DK346987D0 (da) Fremgangsmaade til fremstilling af tetrahydrofuranforbindelser
DK234687A (da) Fremgangsmaade til fremstilling af ribitylxylidin
DK555087A (da) Fremgangsmaade til fremstilling af n-acyl-n-alkyl-2,6-dialkyl-3-chloraniliner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment